Titan International director Maurice M. Taylor Jr. reported receiving a grant of 24,725 shares of common stock as a compensation award, at a stated price of $0.00 per share. These are restricted stock units that vest on the first anniversary of the grant date.
After this award, he directly holds 677,356 shares of common stock. He also holds stock options over 20,000 underlying shares at an exercise price of $11.845, expiring on June 13, 2028, and options over 29,200 underlying shares at an exercise price of $11.79, expiring on June 14, 2027.
Guinn Max A reported acquisition or exercise transactions in this Form 4 filing.
TITAN INTERNATIONAL INC director Max A. Guinn received an equity grant of 24,725 shares of common stock as Restricted Stock Units. The RSUs vest on the first anniversary of the grant date and were recorded at a price of $0.00 per share, reflecting a stock-based compensation award rather than an open-market purchase.
Following this grant, Guinn directly holds 190,061 shares of Titan International common stock, indicating this is a routine compensation-related increase in his equity stake rather than a discretionary trading decision.
TITAN INTERNATIONAL INC director Anthony L. Soave reported an equity award that increases his share-based holdings. He received 24,725 shares of common stock in the form of Restricted Stock Units at a price of $0.00 per share, which vest on the first anniversary of the grant date.
After this award, he directly holds 1,193,348 shares of common stock and indirectly holds 5,000 shares through Brambleton Investments LLC. He also holds stock options covering 20,000 shares at an exercise price of $11.845 per share expiring on June 13, 2028, and 20,000 shares at $11.79 per share expiring on June 14, 2027.
Thompson Laura K reported acquisition or exercise transactions in this Form 4 filing.
TITAN INTERNATIONAL INC director Laura K. Thompson received an equity award in the form of restricted stock units. On the reported date, she was granted 12,362 shares of common stock at no purchase price as a compensation-related award, rather than an open-market transaction.
After this grant, Thompson directly holds 59,377 shares of Titan International common stock. The award represents restricted stock units that will vest on the first anniversary of the grant date, meaning she receives the full benefit only if she remains eligible through that period.
RACHESKY MARK H MD reported acquisition or exercise transactions in this Form 4 filing.
Titan International director Mark H. Rachesky, MD received a compensation grant of restricted stock units (RSUs). On June 23, 2026 he was awarded 24,725 RSUs tied to Titan International common stock at a reference value of $7.28 per share. According to the grant terms, these RSUs are payable upon vesting in an equal number of common shares and are scheduled to vest on June 23, 2027. The filing also reports a separate direct holding entry of 267,358 shares of common stock as of the same date.
TITAN INTERNATIONAL INC executive Max Narancich, COO of Carlstar, reported a routine tax-related share disposition. The company withheld 1,461 shares of common stock at $7.54 per share to satisfy tax withholding obligations tied to the vesting of restricted stock, rather than an open-market sale.
After this withholding, Narancich directly holds 85,737 common shares, including 64,334 shares of restricted stock. These restricted shares are scheduled to vest in tranches on 3/10/27, 6/20/27, 3/10/28, and 3/10/29, indicating ongoing equity-based compensation.
Titan International, Inc. reported the results of its annual meeting of stockholders held on June 18, 2026. Stockholders elected seven directors to one-year terms, ratified the selection of BDO USA P.C. as independent auditor for the year ending December 31, 2026, and approved a non-binding advisory resolution on 2025 executive compensation.
A total of 52,036,730 shares, or 80.83% of the 64,371,960 shares outstanding on the record date, were represented in person or by proxy. Each director nominee received more votes "for" than "withheld," the auditor ratification received over 51.7 million votes in favor, and the say-on-pay proposal received over 45.1 million votes in favor.
Titan International Inc. disclosure: Donald Smith & Co., Inc. reports beneficial ownership of 4,941,157 shares of Common Stock, representing 7.72% of the class as listed on the Schedule 13G with an as of date of 03/31/2026.
The filing states Donald Smith & Co., Inc. acts as investment adviser for institutional clients and that the ultimate power to receive dividends or proceeds rests with those clients. The filing lists related entities Donald Smith & Co., Inc. and DSCO Value Fund, L.P. and is signed by Richard L. Greenberg as CEO and Co-CIO.
Titan International Inc. ownership filing: BlackRock, Inc. reports beneficial ownership of 3,504,933 shares of Titan International Inc. common stock, representing 5.4% of the class. The filing shows BlackRock has sole voting power for 3,434,677 shares and sole dispositive power for 3,504,933.
The amendment clarifies reporting business units and attaches an exhibit for Item 7; the filing is signed by a Managing Director on behalf of BlackRock.
Titan International, Inc. reported first quarter 2026 net sales of $505.1 million, up 2.9% from $490.7 million a year ago, driven mainly by foreign currency tailwinds and pricing, partly offset by lower volumes in agricultural and consumer markets. Gross margin edged up to 14.1%. The company posted a net loss attributable to common shareholders of $24.2 million, or ($0.38) per share, compared with a loss of $0.6 million, largely due to $25.1 million of restructuring and impairment charges tied to closing the Jackson, Tennessee plant. Adjusted EBITDA was $31.4 million, slightly above $30.8 million in 2025, and adjusted net income was roughly break-even. By segment, earthmoving/construction sales rose 11.3% with margin improvement, agriculture was flat, and consumer sales declined 1.6% but kept strong margins. Titan ended the quarter with $171.3 million in cash and $612.6 million of total debt, for net debt of $441.3 million, and used $46.5 million of cash in operating activities, mainly from seasonal working capital. Management guided Q2 2026 sales to $470–$490 million and adjusted EBITDA to $25–$30 million, and reaffirmed full-year 2026 sales guidance of $1.85–$1.95 billion with adjusted EBITDA of $105–$115 million.